SPC311
Samsetning af (a) 3-(6-(1-(2,2-díflúorbensó[d][1,3]díoxól-5-ýl)sýklóprópankarboxamídó)-3-metýlpýridín-2-ýl)bensósýru og (b) N-(5-hýdroxý-2,4-dítert-bútýl-fenýl)-4-oxó-1H-kínólín-3-karboxamíð eða lyfjafræðilega viðeigandi salt þess
Status:
VeittApplication date:
14.8.2020Application published:
15.9.2020Grant published:
15.3.2022
Max expiry date:
23.11.2030Medicine name:
OrkambiMedicine for children:
No
Timeline
Today
14.8.2020Application
15.9.2020Publication
15.3.2022Registration
23.11.2030Expires
Marketing license
IS authorization number:
EU/1/15/1059/001Date:
8.12.2015
Foreign authorization number:
EU/1/15/1059Date:
19.11.2015
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, Boston, MA 02210 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3170818